Shazah Khawaja, MD
Obstetrics/Gynecology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 6
Offices
6 locations
Hospitals listed: California Pacific Medical Ctr-Davies Campus Hosp · Healdsburg Hospital · Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khawaja’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C55816 · Current
Licensed to practise in California · since 2013 · expires 2026-09-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- New Jersey 25MA08177000Medical Doctor · since 2006 · expires 2015-06-30ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Healdsburg HospitalHealdsburg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Providence, which runs 54 hospitals in 7 states77% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Healdsburg Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 1 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 45 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 109 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.8 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 84% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Year by year
| 2023 | 47 | 100 | 72 | 0.88 | $34,058 | $5,503 |
| 2022 | 123 | 435 | 69 | 0.77 | $145,091 | $30,633 |
| 2021 | 166 | 512 | 71 | 0.80 | $99,587 | $40,949 |
| 2020 | 185 | 824 | 70 | 0.94 | $98,399 | $38,081 |
| 2019 | 257 | 1,063 | 71 | 1.03 | $166,910 | $61,418 |
| 2018 | 218 | 758 | 70 | 1.03 | $100,788 | $38,475 |
| 2017 | 149 | 473 | 69 | 1.02 | $74,539 | $26,253 |
| 2016 | 185 | 542 | 65 | 0.91 | $99,346 | $33,039 |
| 2015 | 170 | 450 | 68 | 0.99 | $94,186 | $31,948 |
| 2014 | 85 | 155 | 67 | 1.12 | $34,219 | $13,310 |
| 2013 | 87 | 164 | 49 | 0.97 | $15,614 | $5,033 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 15 | $689 | $41 |
| Assessment of emotional or behavioral problems | 17 | $47 | $2 |
2022: 6 services
| Short return visit (20+ min) | 78 | $8,992 | $72 |
| New patient visit (30+ min) | 18 | $1,749 | $97 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 32 | $1,380 | $43 |
| Return visit (30+ min) | 12 | $1,342 | $96 |
| Short return visit | 15 | $797 | $42 |
| Assessment of emotional or behavioral problems | 62 | $422 | $4 |
2021: 7 services
| Insertion of lower leg neurostimulator electrode | 12 | $7,316 | $116 |
| Short return visit (20+ min) | 70 | $7,095 | $71 |
| Return visit (30+ min) | 46 | $5,618 | $100 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 60 | $2,932 | $49 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 64 | $2,770 | $43 |
| New patient visit (45+ min) | 23 | $2,738 | $119 |
| Annual depression screening, 5 to 15 minutes | 67 | $1,407 | $21 |
2020: 6 services
| Insertion of lower leg neurostimulator electrode | 19 | $12,096 | $109 |
| Short return visit (20+ min) | 85 | $6,592 | $58 |
| Return visit (30+ min) | 40 | $3,011 | $68 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 52 | $2,253 | $43 |
| New patient visit (30+ min) | 20 | $1,415 | $71 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,007 | $48 |
2019: 9 services
| Insertion of lower leg neurostimulator electrode | 35 | $20,683 | $109 |
| Return visit (30+ min) | 91 | $10,839 | $80 |
| Short return visit (20+ min) | 73 | $6,225 | $59 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 83 | $3,420 | $41 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 50 | $2,345 | $47 |
| New patient visit (45+ min) | 17 | $1,600 | $94 |
| New patient visit (30+ min) | 14 | $1,272 | $91 |
| Short return visit | 27 | $1,122 | $35 |
| Urinalysis, manual test | 11 | $38 | $3 |
2018: 7 services
| Insertion of lower leg neurostimulator electrode | 22 | $8,418 | $109 |
| Return visit (30+ min) | 65 | $7,165 | $82 |
| Short return visit (20+ min) | 58 | $4,135 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 82 | $3,211 | $39 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 49 | $2,279 | $47 |
| New patient visit (45+ min) | 18 | $1,973 | $110 |
| New patient visit (30+ min) | 11 | $968 | $88 |
2017: 5 services
| Return visit (30+ min) | 54 | $6,622 | $85 |
| New patient visit (45+ min) | 22 | $2,602 | $118 |
| Short return visit (20+ min) | 41 | $2,460 | $49 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 42 | $1,645 | $39 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $972 | $46 |
2016: 5 services
| Return visit (30+ min) | 59 | $6,018 | $76 |
| Short return visit (20+ min) | 82 | $5,293 | $51 |
| New patient visit (45+ min) | 36 | $3,583 | $100 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 37 | $1,429 | $39 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,196 | $46 |
2015: 6 services
| Short return visit (20+ min) | 68 | $5,994 | $56 |
| New patient visit (45+ min) | 38 | $5,012 | $132 |
| Return visit (30+ min) | 33 | $3,553 | $87 |
| New patient visit (30+ min) | 18 | $1,394 | $77 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,382 | $39 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,223 | $47 |
2014: 3 services
| Short return visit (20+ min) | 43 | $3,754 | $60 |
| New patient visit (30+ min) | 17 | $1,416 | $83 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 19 | $739 | $39 |
2013: 5 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 23 | $1,003 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $741 | $53 |
| Short return visit | 16 | $607 | $34 |
| Injection of drug or substance under skin or into muscle | 12 | $337 | $20 |
| Insertion of needle into vein for collection of blood sample | 46 | $140 | $3 |
Medicaid work
$764 in 2023
Medicaid paid $764 for 42 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $386 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 29 | $377 |
| 2023 | 42 | 2 | 15 | $764 |
| 2022 | 237 | 2 | 26 | $7,996 |
| 2021 | 205 | 2 | 22 | $8,793 |
| 2020 | 382 | 4 | 29 | $30,268 |
| 2019 | 781 | 6 | 52 | $74,498 |
| 2018 | 405 | 4 | 29 | $37,312 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 211 | $7,584 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 26 | $412 |
2021
| Short return visit (20+ min) | 162 | $5,022 |
| Prenatal care, at-risk enhanced service; antepartum management | 43 | $3,771 |
2020
| Prenatal care, at-risk enhanced service; antepartum management | 260 | $21,803 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 47 | $5,259 |
| Short return visit (20+ min) | 61 | $2,499 |
| Return visit (30+ min) | 14 | $707 |
2019
| ANTEPARTUM CARE ONLY 4-6 VISITS | 508 | $56,840 |
| Service | 87 | $4,763 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 74 | $4,444 |
| Return visit (30+ min) | 51 | $3,407 |
| Long return visit (40+ min) | 13 | $3,038 |
| Short return visit (20+ min) | 48 | $2,007 |
2018
| ANTEPARTUM CARE ONLY 4-6 VISITS | 302 | $33,679 |
| Return visit (30+ min) | 26 | $1,765 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 25 | $1,079 |
| FETAL NON-STRESS TEST | 52 | $789 |
Drugs they prescribed that Part D paid
$26,610
Pharmacies billed $26,610 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
214 generic and 18 brand-name prescriptions · $26,610 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 64 | $3,211 | $50 |
| Progesterone | 34 | $1,301 | $38 |
| Dotti | 11 | $1,021 | $93 |
| Valacyclovir | 14 | $956 | $68 |
Year by year
| 2024 | 232 | 70 | None | 8% | $26,610 |
| 2023 | 191 | 65 | None | 13% | $25,114 |
| 2022 | 269 | 82 | 4% (11) | 19% | $39,766 |
| 2021 | 377 | 114 | None | 18% | $50,717 |
| 2020 | 303 | 100 | None | 23% | $45,724 |
| 2019 | 354 | 101 | None | None | $37,544 |
| 2018 | 226 | 87 | None | 16% | $24,941 |
| 2017 | 233 | 78 | None | 19% | $21,447 |
| 2016 | 217 | 77 | 6% (12) | 30% | $24,257 |
| 2015 | 183 | 60 | 7% (13) | 45% | $20,689 |
| 2014 | 166 | 60 | None | 34% | $11,676 |
| 2013 | 342 | 84 | None | 36% | $18,567 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol | 51 | $3,272 | $64 |
| Progesterone | 26 | $1,589 | $61 |
| Valacyclovir | 13 | $690 | $53 |
2022: 6 drugs
| Premarin | 18 | $7,707 | $428 |
| Estradiol | 64 | $4,383 | $68 |
| Progesterone | 28 | $2,817 | $101 |
| Valacyclovir | 22 | $1,647 | $75 |
| Pirmella | 11 | $287 | $26 |
| Sertraline | 12 | $104 | $9 |
2021: 9 drugs
| Myrbetriq | 15 | $9,769 | $651 |
| Estradiol | 92 | $7,520 | $82 |
| Premarin | 14 | $5,890 | $421 |
| Progesterone | 36 | $3,111 | $86 |
| Dotti | 14 | $1,805 | $129 |
| Valacyclovir | 23 | $1,129 | $49 |
| Metronidazole | 16 | $76 | $5 |
| Sertraline | 13 | $72 | $6 |
| Ciprofloxacin | 11 | $70 | $6 |
2020: 7 drugs
| Estradiol | 63 | $5,450 | $87 |
| Premarin | 13 | $5,323 | $409 |
| Progesterone | 30 | $3,064 | $102 |
| Dotti | 15 | $1,584 | $106 |
| Valacyclovir | 14 | $1,098 | $78 |
| Nitrofurantoin Mono-Macro | 11 | $219 | $20 |
| Medroxyprogesterone Acetate | 11 | $81 | $7 |
2019: 7 drugs
| Premarin | 23 | $9,115 | $396 |
| Estradiol | 93 | $6,581 | $71 |
| Progesterone | 40 | $2,852 | $71 |
| Valacyclovir | 14 | $789 | $56 |
| Clotrimazole-Betamethasone | 12 | $219 | $18 |
| Medroxyprogesterone Acetate | 22 | $204 | $9 |
| Metronidazole | 14 | $176 | $13 |
2018: 7 drugs
| Premarin | 14 | $4,934 | $352 |
| Estradiol | 43 | $3,371 | $78 |
| Progesterone | 22 | $1,116 | $51 |
| Clotrimazole-Betamethasone | 13 | $724 | $56 |
| Valacyclovir | 18 | $702 | $39 |
| Metronidazole | 15 | $359 | $24 |
| Medroxyprogesterone Acetate | 12 | $122 | $10 |
2017: 7 drugs
| Estrace | 22 | $6,620 | $301 |
| Premarin | 11 | $3,693 | $336 |
| Estradiol | 39 | $960 | $25 |
| Clotrimazole-Betamethasone | 19 | $599 | $32 |
| Progesterone | 11 | $521 | $47 |
| Metronidazole | 14 | $119 | $9 |
| Medroxyprogesterone Acetate | 14 | $111 | $8 |
2016: 5 drugs
| Estrace | 18 | $4,974 | $276 |
| Vivelle-Dot | 12 | $1,392 | $116 |
| Estradiol | 29 | $1,158 | $40 |
| Clotrimazole-Betamethasone | 21 | $664 | $32 |
| Ibuprofen | 16 | $61 | $4 |
2015: 3 drugs
| Premarin | 14 | $3,714 | $265 |
| Estrace | 16 | $3,568 | $223 |
| Estradiol | 24 | $1,466 | $61 |
2014: 5 drugs
| Premarin | 11 | $2,363 | $215 |
| Estrace | 13 | $2,050 | $158 |
| Progesterone | 12 | $1,203 | $100 |
| Vivelle-Dot | 11 | $935 | $85 |
| Fluconazole | 13 | $122 | $9 |
2013: 9 drugs
| Medroxyprogesterone Acetate | 40 | $1,523 | $38 |
| Kariva | 29 | $1,353 | $47 |
| Clotrimazole-Betamethasone | 12 | $675 | $56 |
| Alendronate | 55 | $594 | $11 |
| Aviane | 19 | $421 | $22 |
| Ocella | 13 | $402 | $31 |
| Tri-Sprintec | 14 | $323 | $23 |
| Lutera | 11 | $245 | $22 |
| Ibuprofen | 11 | $60 | $5 |
Money from drug and device companies
$203 in 2025
| 2025 | 4 | 7 | None | $203 |
| 2024 | 6 | 14 | None | $633 |
| 2023 | 8 | 22 | None | $657 |
| 2022 | 10 | 19 | None | $524 |
| 2021 | 15 | 35 | $2,100 | $2,640 |
| 2020 | 6 | 13 | None | $266 |
| 2019 | 14 | 28 | None | $616 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Myosure Tissue Removal Device | $74 | 2 payments
|
| Sumitomo Pharma America | Myfembree | $53 | 2 payments
|
| Mayne Pharma Commercial | None | $45 | 2 payments
|
| Organon | Nexplanon | $32 | 1 payment
|
See all 7 published payments
| Organon | Meals · 2025-12-17 | Nexplanon | $32 |
| Hologic Sales and Service | Meals · 2025-12-05 | Myosure Tissue Removal Device | $60 |
| Mayne Pharma Commercial | Meals · 2025-11-13 | None | $28 |
| Hologic Sales and Service | Meals · 2025-11-07 | Fluent Fluid Management System | $14 |
| Sumitomo Pharma America | Meals · 2025-10-29 | Myfembree | $28 |
| Mayne Pharma Commercial | Meals · 2025-09-10 | None | $17 |
| Sumitomo Pharma America | Meals · 2025-06-11 | Myfembree | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $633
| Hologic Sales and Service | Fluent Fluid Management System | $354 | 5 payments
|
| Astellas Pharma US | Veozah | $135 | 3 payments
|
| Mayne Pharma Commercial | None | $62 | 3 payments
|
| Amgen | Evenity | $32 | 1 payment
|
| Organon | Nexplanon | $25 | 1 payment
|
| Abbvie | Botox | $24 | 1 payment
|
2023: $657
| Astellas Pharma US | Myrbetriq | $229 | 5 payments
|
| Hologic Sales and Service | Acessa Provu System | $219 | 6 payments
|
| Pfizer | Myfembree | $62 | 3 payments
|
| Organon | Nexplanon | $48 | 2 payments
|
| Mayne Pharma Commercial | None | $41 | 3 payments
|
| Avanos Medical | On-Q* Pump and Accessories | $26 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $19 | 1 payment
|
| Novo Nordisk | Wegovy | $14 | 1 payment
|
2022: $524
| Hologic | Acessa Provu System | $145 | 2 payments
|
| Abbvie | Lo Loestrin Fe | $98 | 4 payments
|
| Mayne Pharma | None | $59 | 3 payments
|
| Myovant Sciences | Myfembree | $54 | 2 payments
|
| Pfizer | Premarin | $47 | 2 payments
|
| Organon | Nexplanon | $37 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $26 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $21 | 1 payment
|
| Aspira Women's Health | Ova1 | $20 | 1 payment
|
| Evofem Biosciences | Phexxi | $17 | 1 payment
|
2021: $2,640
| AbbVie | Orilissa | $2,207 | 12 payments
|
| TherapeuticsMD | Annovera | $90 | 5 payments
|
| Organon | Nexplanon | $52 | 3 payments
|
| Evofem Biosciences | Phexxi | $51 | 3 payments
|
| Pfizer | Premarin | $38 | 2 payments
|
| Hologic | Thinprep 2000 Processor | $27 | 1 payment
|
| Ethicon US | Enseal X1 | $25 | 1 payment
|
| Myovant Sciences | Myfembree | $22 | 1 payment
|
| Amgen | Evenity | $21 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $21 | 1 payment
|
| Abbott Laboratories | Proclaim Ipg | $19 | 1 payment
|
| Roche Diagnostics | Cobas 6800 System | $18 | 1 payment
|
| Agile Therapeutics | Twirla | $18 | 1 payment
|
| CooperSurgical | Endosee | $16 | 1 payment
|
| Lupin | Solosec | $15 | 1 payment
|
2020: $266
| Amgen | Evenity | $91 | 4 payments
|
| AbbVie | Orilissa | $63 | 3 payments
|
| Hologic | Aptima Hpv | $41 | 2 payments
|
| Avion Pharmaceuticals | Balcoltra | $28 | 2 payments
|
| Ethicon US | Stratafix | $22 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $21 | 1 payment
|
2019: $616
| TherapeuticsMD | Imvexxy | $116 | 3 payments
|
| Amgen | Evenity | $107 | 4 payments
|
| Roche Diagnostics | Rs Harmony Test Related Products | $68 | 3 payments
|
| AbbVie | Orilissa | $67 | 3 payments
|
| Merck Sharp & Dohme | Nexplanon | $51 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Mirena | $46 | 2 payments
|
| AMAG Pharmaceuticals | Vyleesi | $31 | 2 payments
|
| Allergan | Lo Loestrin Fe | $31 | 2 payments
|
| Mallinckrodt Enterprises | Ofirmev | $19 | 1 payment
|
| Medtronic Vascular | Venaseal | $19 | 1 payment
|
| CooperSurgical | Endosee | $18 | 1 payment
|
| Daiichi Sankyo | Injectafer | $16 | 1 payment
|
| Avion Pharmaceuticals | Prenate Mini | $15 | 1 payment
|
| Hologic | Novasure | $11 | 1 payment
|
Checkups this office reported
2023
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1083636450
- Licence
- CA C55816, CT 048447, NJ 25MA08177000, NY 239820California C55816: Current · expires 2026-09-30New Jersey 25MA08177000: Expired
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VX0000X (207VX0000X)
- Mailing address
- 900 Sonoma Ave Ste 18, Santa Rosa, CA, 95404
- NPI first listed
- 2006-07-24
- NPI last updated
- 2025-06-16
- NPI record certified
- 2025-06-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 20642 John Dr, Castro Valley, CA, 94546